Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa Hodeib

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Oncotarget|February 10, 2018
Metformin induces distinct bioenergetic and metabolic profiles in sensitive versus resistant high grade serous ovarian cancer and normal fallopian tube secretory epithelial cellsMelissa Hodeib, Martin P Ogrodzinski, Laurent Vergnes, et al.
Gynecologic Oncology|April 28, 2015
Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancerMelissa Hodeib, Jenny Chang, Fong Liu, et al.
Gynecologic Oncology Reports|January 26, 2026
COVID-19 pandemic and healthcare utilization in ovarian cancer patientsAmrita Mukherjee, Natalie Ayoub, Lanfang Xu, et al.
Frontiers in Oncology|April 11, 2024
Impact of the Coronavirus Disease 2019 pandemic on neoadjuvant chemotherapy use in patients diagnosed with epithelial type ovarian cancerAmrita Mukherjee, Natalie Shammas, Lanfang Xu, et al.
Gynecologic Oncology|April 2, 2016
Recurrence and risk of progression to lower genital tract malignancy in women with high grade VAINMelissa Hodeib, Joshua G Cohen, Sukrant Mehta, et al.
American Journal of Obstetrics and Gynecology|August 15, 2013
Impact of a multivariate index assay on referral patterns for surgical management of an adnexal massRobert E Bristow, Melissa Hodeib, Alan Smith, et al.
Gynecologic Oncology Reports|June 9, 2025
Impact of the COVID-19 pandemic on cancer recurrence rates in patients with ovarian cancerAmrita Mukherjee, Natalie Ayoub, Lanfang Xu, et al.
Cancer Management and Research|February 18, 2025
Clinical Remission Rates in Patients With Epithelial Ovarian Cancer Before and After the Onset of the COVID 19 Pandemic in an Integrated Healthcare Delivery SystemAmrita Mukherjee, Natalie Ayoub, Lanfang Xu, et al.
MMWR. Morbidity and Mortality Weekly Report|January 28, 2021
Impact of COVID-19 on Cervical Cancer Screening Rates Among Women Aged 21-65 Years in a Large Integrated Health Care System - Southern California, January 1-September 30, 2019, and January 1-September 30, 2020Maureen J Miller, Lanfang Xu, Jin Qin, et al.
Contemporary Clinical Trials|November 6, 2022
A study protocol for a cluster randomized pragmatic trial for comparing strategies for implementing primary HPV testing for routine cervical cancer screening in a large health care systemChun R Chao, Nancy T Cannizzaro, Erin E Hahn, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Oncotarget|February 10, 2018
Metformin induces distinct bioenergetic and metabolic profiles in sensitive versus resistant high grade serous ovarian cancer and normal fallopian tube secretory epithelial cellsMelissa Hodeib, Martin P Ogrodzinski, Laurent Vergnes, et al.
Gynecologic Oncology|April 28, 2015
Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancerMelissa Hodeib, Jenny Chang, Fong Liu, et al.
Gynecologic Oncology Reports|January 26, 2026
COVID-19 pandemic and healthcare utilization in ovarian cancer patientsAmrita Mukherjee, Natalie Ayoub, Lanfang Xu, et al.
Frontiers in Oncology|April 11, 2024
Impact of the Coronavirus Disease 2019 pandemic on neoadjuvant chemotherapy use in patients diagnosed with epithelial type ovarian cancerAmrita Mukherjee, Natalie Shammas, Lanfang Xu, et al.
Gynecologic Oncology|April 2, 2016
Recurrence and risk of progression to lower genital tract malignancy in women with high grade VAINMelissa Hodeib, Joshua G Cohen, Sukrant Mehta, et al.
American Journal of Obstetrics and Gynecology|August 15, 2013
Impact of a multivariate index assay on referral patterns for surgical management of an adnexal massRobert E Bristow, Melissa Hodeib, Alan Smith, et al.
Gynecologic Oncology Reports|June 9, 2025
Impact of the COVID-19 pandemic on cancer recurrence rates in patients with ovarian cancerAmrita Mukherjee, Natalie Ayoub, Lanfang Xu, et al.
Cancer Management and Research|February 18, 2025
Clinical Remission Rates in Patients With Epithelial Ovarian Cancer Before and After the Onset of the COVID 19 Pandemic in an Integrated Healthcare Delivery SystemAmrita Mukherjee, Natalie Ayoub, Lanfang Xu, et al.
MMWR. Morbidity and Mortality Weekly Report|January 28, 2021
Impact of COVID-19 on Cervical Cancer Screening Rates Among Women Aged 21-65 Years in a Large Integrated Health Care System - Southern California, January 1-September 30, 2019, and January 1-September 30, 2020Maureen J Miller, Lanfang Xu, Jin Qin, et al.
Contemporary Clinical Trials|November 6, 2022
A study protocol for a cluster randomized pragmatic trial for comparing strategies for implementing primary HPV testing for routine cervical cancer screening in a large health care systemChun R Chao, Nancy T Cannizzaro, Erin E Hahn, et al.
Pageof 3